INNOVATIVE MEDTECH, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q1 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Innovative Medtech, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q1 2024.
Innovative Medtech, Inc. Debt-to-equity for the quarter ending March 31, 2024 was -412 %, a 57.5% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	-412	-150	-57.5%	Mar 31, 2024
Q4 2023	-308	+41.3	+11.8%	Dec 31, 2023
Q3 2023	-275	+240	+46.7%	Sep 30, 2023
Q2 2023	-260	+637	+71%	Jun 30, 2023
Q1 2023	-261	+1.65K	+86.3%	Mar 31, 2023
Q4 2022	-349			Dec 31, 2022
Q3 2022	-515			Sep 30, 2022
Q2 2022	-897			Jun 30, 2022
Q1 2022	-1.91K			Mar 31, 2022
Q3 2014	-100	-0.01	-0.01%	Oct 31, 2014
Q2 2014	-100	0	0%	Jul 31, 2014
Q1 2014	-100			Apr 30, 2014
Q4 2013	-100			Jan 31, 2014
Q3 2013	-100			Oct 31, 2013
Q2 2013	-100			Jul 31, 2013
Q1 2012	-105			Apr 30, 2012

* An asterisk sign (*) next to the value indicates that the value is likely invalid.